The Patent Finder

Allergan Botox Limited

Also on record
Records under this name other than patents Allergan Botox Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Showing 1 to 3 of 3 · Back to Allergan Botox Limited

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 6,087,327Compositions and methods for chemodenervation using neurotoxins
Formerly held
Term ended
Term ended Jan 30, 2018 · USPTO record
Term endedTerm ended Jan 30, 2018USPTO record
US 6,063,768Application of botulinum toxin to the management of neurogenic inflammatory disorders
Formerly held
Term ended
Term ended Sep 4, 2017 · USPTO record
Term endedTerm ended Sep 4, 2017USPTO record
US 6,967,088Soluble recombinant botulinum toxin proteins
Lapsed on the fee record
Ended Nov 22, 2013 · USPTO record
Lapsed on the fee recordEnded Nov 22, 2013USPTO record
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited